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Abstract
The purpose of this study is to establish if hydroxytyrosol and oleuropein, the 
most significant phenols found in olive oil and olives, can inhibit the activation 
of mast cells induced by immune and nonimmune pathways. Preincubation of 
purified peritoneal mast cells was carried out in the presence of hydroxytyrosol or 
oleuropein compounds and, prior to incubation, with concanavalin A, compound 
48/80, or calcium ionophore A23187. Dose-response and time-dependence were 
studied. Comparative studies were performed using sodium cromoglycate, a 
well-known mast cell stabilizer. The supernatants and pellets were analyzed for 
β-hexosaminidase content via colorimetric reaction after incubation. The per-
centage of β-hexosaminidase obtained in each tube was measured and taken as a 
referent mast cell activation indicator. Other cell pellet samples were studied for 
cell viability, by means of the trypan blue exclusion method, or analyzed with light 
and electron microscopy. For the first time, biochemical and morphological results 
have shown that hydroxytyrosol and oleuropein inhibit degranulation of mast cells 
triggered by both immune and nonimmune causes. These findings suggest that olive 
phenols, specifically hydroxytyrosol and oleuropein, may be set the bases for devel-
oping practical tools not only to prevent and treat mast cell-mediated disorders but 
also to improve olive oil industrialization.
Keywords: β-hexosaminidase, degranulation, hydroxytyrosol, mast cell, oleuropein, 
olive
1. Introduction
Mast cells are key effector cells that clearly play both physiological and patho-
physiological functions in the body [1]. In vertebrates, mast cells are widely dis-
tributed in the tissues, especially near surfaces exposed to the environment, where 
pathogens, allergens, and other environmental agents are frequently found. Due 
to this distribution pattern, they are some of the first cells involved in the immune 
response which interact with environmental antigens and allergens, invading 
pathogens or environmentally derived toxins [2]. Mast cells have been involved in 
the pathogenesis of a number of disorders including contact dermatitis, allergic rhi-
nitis, asthma, atopic dermatitis, bullous pemphigoid, fibrotic lung disease, cancer, 
multiple sclerosis, neurofibromatosis, psoriasis, scleroderma, rheumatoid arthritis, 
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interstitial cystitis, ulcerative colitis, peptic ulcer, and Crohn’s disease [1, 3–7]. 
Understanding mast cells is essential for the pathophysiological bases of this type of 
disorders since these cells release varied inflammatory mediators prompted by both 
immune and nonimmune causes. Among mast cell mediators, preformed molecules 
can be mentioned, for example, histamine and proteases, which are accumulated 
in secretory granules [7–9]. The immediate response upon mast cell activation to 
an appropriate stimulus is called degranulation, characterized by the extrusion 
of cytoplasmic granule contents into the extracellular space by a process called 
exocytosis [10]. In this context, the exploration of interactions of mast cells with 
molecules capable of modulating mediator release from cell granules is a promising 
field for the treatment of mast cell-mediated diseases.
In vitro and in vivo studies have shown that several plant products with 
antioxidant properties inhibit mast cell activation induced by both immune and 
nonimmune secretagogues [11–14]. Recent scientific evidence from preclinical 
studies and clinical trials including humans has highlighted different nutritional 
interventions, such as dietary polyphenols, as promising agents able to alleviate 
symptoms associated with mast cell activation [15]. Dietary polyphenols are a class 
of bioactive compounds found in abundance in plants and fruits which have been 
studied thoroughly in several disease models [15]. The pulp of olives contains these 
compounds, which are hydrophilic, and they are also found in the oil. The class of 
phenols includes numerous substances, such as simple phenolic compounds like 
hydroxytyrosol and more complex compounds like oleuropein [16]. Hydroxytyrosol 
and oleuropein, the major phenols found in olives, are used in disease prevention 
because they have important antioxidant and anti-inflammatory properties [17, 18].  
Several in vitro and in vivo studies have shown that oleuropein and its derivate 
hydroxytyrosol possess a wide range of biochemical and pharmacological proper-
ties. However, no studies have been published on the effects of these molecules on 
mast cell degranulation.
We carried out a series of experiments to determine the effects of both phenolic 
compounds on mast cell degranulation and thus explore the possibility that oleuro-
pein and hydroxytyrosol might inhibit in vitro mast cell activation.
The biochemical and morphological findings of the present study showed for 
the first time that hydroxytyrosol and oleuropein inhibit the degranulation of mast 
cells induced by both immune and nonimmune pathways.
2. Material and methods
2.1 Chemicals and reagents
The compound molecules, hydroxytyrosol and oleuropein, were provided by 
Extrasynthèse (Lyon, France). Figure 1 shows the polyphenol chemical structure. 
A solution containing 6.7 mM Na2HPO4, 6.7 mM KH2PO4, 137 mM NaCl, 2.7 mM 
KCl, 0.8 mM CaCl2, 0.5 g/l albumin, and 1 g/l glucose was used for dissolving the 
polyphenols, which was adjusted to pH 7.2 and stored at −20°C. The same solu-
tion was used for diluting the stock solutions until the final concentration was 
reached. Bovine serum albumin (fraction V), concanavalin A, compound 48/80, 
calcium ionophore A23187, sodium cromoglycate, 4-nitrophenyl-N-acetyl-β-D-
glucosaminide, toluidine blue, trypan blue, glutaraldehyde, formaldehyde, and 
osmium tetroxide were acquired from Sigma (St. Louis, MO, USA). Percoll was 
purchased from GE Healthcare (Munich, Germany). All other substances were 
provided by Merck (Darmstadt, Germany). The highest quality available is guaran-
teed in all the chemicals used for this study.
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2.2 Animals
Adult male 300–500 g Wistar rats free from infections were used for the study. 
They were kept under a 12-h dark/light cycle in a room set at 24–25°C with free 
access to laboratory food and drinking water. Animals experiments were carried 
out according with the standards contained in the Guide for the Care and Use of 
Laboratory Animals, published by the National Academy of Sciences, National 
Academies Press, Washington, DC, and accepted by the Institutional Committee 
for Care and Use of Laboratory Animals (CICUAL, Facultad de Ciencias Médicas, 
Universidad Nacional de Cuyo, Mendoza, Argentina).
2.3 Mast cell isolation and purification
Isolation of mast cells was performed by means of peritoneal lavage as described 
before [19] with some modifications. Rats were killed by CO2 inhalation and then 
injected with 20 ml of a pH 7.2 solution containing 6.7 mM Na2HPO4, 6.7 mM 
KH2PO4, 137 mM NaCl, 2.7 mM KCl, 0.8 mM CaCl2, 0.5 g/l albumin, and 1 g/l glu-
cose, into the peritoneal cavity. A gentle massage was applied on the abdomen for 
about 3 min. After the peritoneal cavity was opened with care, a Pasteur pipette was 
used for aspirating the fluid with peritoneal cells, which were then purified via cen-
trifugation through a discontinuous gradient of Percoll per reports by MacGlashan 
and Guo [20]. It was easy to harvest the mast cells since they precipitated to the 
bottom of the tube and formed a layer, different from the other cells that formed a 
rather compact layer on top of the gradient and were simply removed by aspiration. 
Cell metachromatic staining was carried out with toluidine blue (0.1% w/v, pH 1.0), 
and quantification required a Neubauer hemocytometer under a Nikon microscope 
(magnification 200×). Mast cells were present in the crude peritoneal suspended 
content by 3%, and, after gradient centrifugation, their purity rose to over 95%. 
After washing purified mast cells, resuspension was performed in a balanced salt 
Figure 1. 
Structural formulas of polyphenols used in this study.
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solution with 6.7 mM Na2HPO4, 6.7 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 
0.8 mM CaCl2, 0.5 g/l albumin, and 1 g/l glucose, adjusted to pH 7.2 (cell density 
of 1 × 106/ml) and kept at 4°C for 30 min at the most. Both the ability of mast cells 
to exclude trypan blue and the amount of β-hexosaminidase in the supernatant 
established mast cell viability. The trypan blue exclusion test determined that the 
mast cells were viable by over 95%. Basal β-Hexosaminidase release remained 
always below 4%.
2.4 General protocol
Purified peritoneal mast cells (cell density of 1 × 106/ml) were balanced at 
37°C for 10 min. Preincubation of 30-μL aliquots of the balanced cells required 
polypropylene tubes at 37°C with hydroxytyrosol or oleuropein. Then, incuba-
tion was carried out at 37°C for 10 min using concanavalin A (final concentration 
was 200 μg/ml, with 50 μg/ml phosphatidylserine as a co-stimulator), compound 
48/80 (concentrated at 10 g/ml), or calcium ionophore A23187 (final concentra-
tion 50 μg/ml). Positive and negative controls, that is, with and without mast cell 
secretagogues stimulation, respectively, were included. Studies on dose–response 
(hydroxytyrosol and oleuropein concentrations of 10, 50, 100, 200, and 400 M) 
and time-dependence (hydroxytyrosol and oleuropein preincubation for 5, 10, 
20, and 45 min) were performed. Comparative studies were performed using 
sodium cromoglycate, a well-known mast cell stabilizer, with identical concentra-
tions and time ranges. Each tube’s final incubation volume reached 100 l. During 
incubations, the average total number of mast cells was 4 × 104/ml per tube. 
Secretion was halted by cooling the tubes in an ice-cold water bath. Cells and 
supernatants were separated by centrifugation (180 g, 5 min, 4°C). The superna-
tants helped determine the β-hexosaminidase content by colorimetric reaction, 
which was a parameter to measure β-hexosaminidase release. The cell pellets were 
lysated with 1% Triton X-100 to release the remaining β-hexosaminidase, which 
was quantified by colorimetric reaction and taken as a measure of the residual 
β-hexosaminidase. Other cell pellet samples were studied for cell viability, by 
means of the trypan blue exclusion method, or analyzed with light and electron 
microscopy. The purpose of cell viability studies was to ascertain that changes 
in β-hexosaminidase release were not caused by cell death. The percentage of 
β-hexosaminidase obtained in each tube was measured. All the tests were per-
formed at least five times in duplicate.
2.5 β-Hexosaminidase assay
β-Hexosaminidase release, as an index of mast cell degranulation, was assayed 
by a colorimetric assay as before explained [21] with some changes. In brief, 50 μL 
of the supernatant was combined with an equal volume of 2 mM substrate solution 
(p-nitrophenyl-N-acetyl-β-D-glucosaminide in 0.2 M citrate, pH 4.5) and then 
incubated for 3 h at 37°C. The reaction was halted by adding 250 μL of stopping 
buffer (0.4 M glycine in Na2CO3/NaHCO3, pH 9). Absorbance was studied with a 
microplate reader at 405 nm (Thermo Scientific Multiskan FC, Helsinki, Finland). 
Results were stated as the percentage of β-hexosaminidase activity released over the 
total (enzyme released plus intracellular enzyme).
2.6 Light microscopy and morphometry
Mast cells were fixed in 2% glutaraldehyde for 2 h. Then, the suspended cells 
were stained with toluidine blue (0.1% w/v, pH 3.0), put between slides and cover 
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slides, and analyzed under a Nikon Optiphot 2 microscope. Using a magnifica-
tion of 400×, percentage of degranulated mast cells was quantified. Mast cell was 
considered active due to the presence of extruded granules near the surface of the 
cell in question or a toluidine blue stain in half or less of the cell.
2.7 Transmission electron microscopy
Karnovsky’s fixative (2% formaldehyde, freshly prepared from paraformalde-
hyde, 2.5% glutaraldehyde, 0.025% CaCl2, 0.1 M cacodylate buffer, pH 7.4) was 
used for mast cell fixation. After 1 h in the fixative at 20°C, mast cells were rinsed 
in 0.2 M cacodylate buffer and postfixed in 1% OsO4 in 0.1 M cacodylate buffer 
for at least 2 h at room temperature and dehydrated in ethanol. Next, suspended 
cells were embedded in Spurr (Pelco, USA). An automatic ultramicrotome (Leica 
Ultracut R, Austria) was used to cut semithin transverse sections (1 μm), which 
were stained with filtered 1% toluidine blue. Ultrathin sections (60 nm) were cut 
with diamond knives, stained with uranyl acetate and lead citrate, mounted on 
grids (Pelco, USA), and examined in a transmission electron microscope (Zeiss EM 
902, Germany).
2.8 Statistical analysis
Results obtained from biochemical and morphometric analyses are presented 
as ±SEM. Variance analysis was used to determine differences between groups, 
followed by Tukey-Kramer multiple comparisons test. P < 0.05 was considered 
statistically significant.
3. Results and discussion
Figure 2 shows the effect of varying concentrations of hydroxytyrosol and 
oleuropein on the mast cells β-hexosaminidase release, induced by concanavalin 
A, compound 48/80, or calcium ionophore A23187. β-Hexosaminidase release was 
significantly increased by incubating mast cells with 200 μg/ml concanavalin A 
or 10 μg/ml compound 48/80 or 50 μg/ml calcium ionophore A23187 solutions, 
as compared with the corresponding value from the basal group (basal release 
was always less than 4%). The concanavalin A-induced effects were inhibited by 
preincubation of mast cells with hydroxytyrosol (10, 50 and 100 μM) or oleuro-
pein (100 μM). Mast cell activation induced by compound 48/80 was inhibited 
by hydroxytyrosol (100 μM) and oleuropein (100 μM). The calcium ionophore 
A23187-induced effects were inhibited by preincubation of mast cells with hydroxy-
tyrosol (100 μM) and oleuropein (10, 50 and 100 μM). The inhibitory action of 
the polyphenols was not accompanied by changes in cell viability (the trypan blue 
exclusion test indicated a viability of greater than 80%), except for polyphenol 
concentrations higher than 100 μM (data not shown).
Figure 3 shows a dose-response comparative study with sodium cromoglycate, a 
mast cell stabilizer, which was used to evaluate the potency of hydroxytyrosol and 
oleuropein. The inhibitory effect of hydroxytyrosol was higher than that obtained 
with sodium cromoglycate at the same concentration (100 μM) when mast cells 
were challenged with concanavalin A. No significant differences were observed 
when mast cells were challenged with compound 48/80. The oleuropein inhibitory 
effect was higher than the one obtained with sodium cromoglycate at the same 
concentrations (10, 50 and 100 μM) when the calcium ionophore A23187 was used 
to challenge mast cells.
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The kinetic study results connected with the effect of hydroxytyrosol and 
oleuropein on β-hexosaminidase release from mast cell are described in Figure 4.
The concanavalin A-induced effect was inhibited by hydroxytyrosol (10 min), 
oleuropein (10 min), and sodium cromoglycate (10 min). Mast cell activation 
induced by compound 48/80 was only inhibited by sodium cromoglycate (5, 10, 
and 20 min). The ionophore A23187-induced effect was inhibited by hydroxyty-
rosol (10 min), oleuropein (5, 10, and 20 min), and sodium cromoglycate (10 and 
20 min). The inhibitory action of the test compounds was not accompanied by 
changes in cell viability (the trypan blue exclusion test indicated a viability of greater 
than 80%), except for incubation times higher than 20 min (data not shown).
Figure 2. 
Effect of varying concentrations of hydroxytyrosol and oleuropein on the concanavalin A-, compound 48/80-, 
and calcium ionophore A23187-induced β-hexosaminidase release from peritoneal mast cells. Mast cells were 
preincubated with increasing concentrations of hydroxytyrosol or oleuropein for 10 min and then stimulated 
with 200 μg/ml concanavalin A, 10 μg/ml compound 48/80, or 50 μg/ml calcium ionophore A23187, for 10 min 
at 37°C. β-Hexosaminidase release was measured by colorimetric reaction with the chromogenic substrate 
p-nitrophenyl-N-acetyl-β-D-glucosaminide. Results are expressed as percentage release of β-hexosaminidase. 
Values are presented as means ± SEM +++P < 0.001 versus basal, *P < 0.05 versus secretagogue, **P < 0.01 versus 
secretagogue, and ***P < 0.001 versus secretagogue.
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Figure 3. 
Effect of hydroxytyrosol and oleuropein on β-hexosaminidase release from rat peritoneal mast cells, 
compared with a reference compound, the mast cell stabilizer sodium cromoglycate. Purified mast cells were 
preincubated with increasing concentrations of hydroxytyrosol, oleuropein, or sodium cromoglycate for 10 min 
and stimulated with 200 μg/ml concanavalin A, 10 μg/ml compound 48/80, or 50 μg/ml calcium ionophore 
A23187 for another 10 min at 37°C. β-Hexosaminidase release was measured by colorimetric reaction with 
the chromogenic substrate p-nitrophenyl-N-acetyl-β-D-glucosaminide. Results are expressed as percentage 
release of β-hexosaminidase. Values are presented as means ± SEM *P < 0.05 versus sodium cromoglycate and 
***P < 0.001 versus sodium cromoglycate.
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As a matter of interest, the main findings of this study evidenced that hydroxy-
tyrosol and oleuropein, at non-cytotoxic concentrations, inhibit β-hexosaminidase 
release from peritoneal mast cells stimulated by different triggers, acting then as 
mast cell stabilizers.
Figure 4. 
Kinetic study related to the effect of hydroxytyrosol or oleuropein preincubation on mast cell β-hexosaminidase 
release, induced by concanavalin A, compound 48/80, or calcium ionophore A23187. Peritoneal mast cells 
were preincubated for increasing times with 100 μM hydroxytyrosol or oleuropein and then stimulated with 
200 μg/ml concanavalin A, 10 μg/ml compound 48/80, or 50 μg/ml calcium ionophore A23187 for 10 min 
at 37°C. β-Hexosaminidase release was measured by colorimetric reaction with the chromogenic substrate 
p-nitrophenyl-N-acetyl-β-D-glucosaminide. Results are expressed as percentage release of β-hexosaminidase. 
Values are presented as means ± SEM +++P < 0.001 versus basal, *P < 0.05 versus secretagogue, **P < 0.01 versus 
secretagogue, and ***P < 0.001 versus secretagogue.
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Mast cell activation is inhibited by several dietary polyphenols, as shown in 
other in vitro studies [11, 15]. A well-studied immunological effect of polyphenols 
such as quercetin is their inhibitory action on degranulation, particularly histamine 
release from mast cells [11, 15, 22]. Quercetin is able to regulate the entry of cal-
cium into mast cells; also the role of apple and grape quercetin and polyphenols in 
inhibiting mast cell degranulation has been thoroughly documented using in vitro 
systems such as the RBL-2H3 assay [11, 15]. Epigallocatechin gallate was found to be 
the active ingredient in green tea extracts for protection against cutaneous inflam-
mation. This compound may also inhibit mast cell histamine release stimulated 
with both a calcium ionophore and an IgE-antigen complex [23]. Kaempferol, 
myricetin, phloretin, and luteolin also proved to be effective inhibitors of histamine 
release [11, 15]. However, hydroxytyrosol and oleuropein were never studied on 
mast cell mediator release in response to either immune or nonimmune triggers.
In addition, we have also proven that the inhibitory effects by hydroxytyro-
sol were stronger than those of oleuropein or the reference compound sodium 
cromoglycate when mast cells were activated by concanavalin A. On the contrary, 
oleuropein resulted to be a more efficient inhibitor of mast cell degranulation 
than hydroxytyrosol or sodium cromoglycate when cells were challenged with 
the calcium ionophore A23187. Table 1 presents EC50 values for each compound. 
These results strongly suggest that the inhibitory activity might be defined by the 
nature of the stimulus for β-hexosaminidase release and the chemical structure 
of both polyphenols. Each of the secretagogues takes a different mast cell activa-
tion pathway, and these pathways may be differentially sensitive to the action of 
hydroxytyrosol or oleuropein. Mast cells may be activated via several different 
mechanisms, among which is the classical pathway known as immunological or 
IgE-mediated mast cell activation, triggered by the cross-linking of FcεRI recep-
tors. Mast cell activation may also be completed in an IgE-independent manner 
using commercially available activators, such as basic secretagogues and calcium 
ionophores. Concanavalin A is a glucose-/mannose-specific lectin that activates 
mast cells by a mechanism similar to the antigen-antibody reaction. This lectin 
causes FcεRI receptors to cluster on cell membranes. In turn, this triggers a series 
of intracellular events leading to the secretion of mast cell mediators by exocy-
tosis. Phosphatidylserine markedly enhances the release of mediators from rat 
mast cells by concanavalin A [24–26]. The synthetic compound 48/80, a basic 
secretagogue, activates heterotrimeric G proteins by enhancing the dissociation of 
GDP from Gα subunits, thus accelerating the event considered as a rate-limiting 
step in conventional G protein activation by receptors coupled to heterotrimeric G 
proteins [27]. Calcium ionophore A23187, a mobile carrier of divalent cations such 
as Ca2+, Mg2+, and double H+, may reduce the level of calcium stored in mitochon-
dria or increase the inflow from the extracellular medium, resulting in a cytosolic 
calcium increase, which may induce mast cell exocytosis and preformed media-
tor release. Calcium release from internal stores has been shown to be related to 
some second messengers, including phospholipase C, phospholipase D, inositol 
Hydroxytyrosol Oleuropein Sodium cromoglycate
Concanavalin A 7.58 ± 4.9 67 ± 5.1 95 ± 8.9
Compound 48/80 61 ± 5.0 59 ± 5.0 97 ± 9.1
Calcium ionophore A23187 64 ± 5.0 22 ± 1.8 54 ± 5.1
Table 1. 
EC50 (μM) ± SEM values for inhibitory activity of hydroxytyrosol, oleuropein, and sodium cromoglycate on 
concanavalin A-, compound 48/80-, and calcium ionophore A23187-induced mast cell activation.
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1,4,5-triphosphate, and diacylglycerol. Degranulation dependent on the influx of 
extracellular calcium may be associated to the members of the SNARE (soluble 
NSF attachment protein receptor) family, such as synaptosome-associated protein 
of 23 kDa (SNAP-23), syntaxin, synaptotagmin, and molecules of the vesicle-
associated membrane protein (VAMP) family which regulate the granule-to-gran-
ule or granule-to-plasma membrane fusion process [28]. Sodium cromoglycate is 
a compound commonly used in the treatment of allergic diseases. The effect of 
sodium cromoglycate is due to its ability to stabilize the mast cell membrane and 
to prevent the release of histamine and inflammatory mediators [29]. Mechanisms 
of the action of sodium cromoglycate include blocking of the influx of calcium 
into mast cells, inhibition of phosphodiesterase, and regulation of phosphoryla-
tion of mast cell proteins [30].
The findings of this study suggest that hydroxytyrosol and oleuropein act at 
different molecular sites. It seems that the hydroxytyrosol inhibitory mechanism 
may be related, at least partially, to inhibition of the cross-linking of high-affinity 
receptors for IgE (FcεRI) or to a probable interaction of the polyphenol with con-
canavalin A. Reports show that polyphenols form soluble and insoluble complexes 
with proteins and may cause them to become hypoallergenic by either modifying 
the structure of the allergenic protein or making it less bioavailable [15]. Moreover, 
two mechanisms are proposed for the mast cell inhibitory action of quercetin and 
other polyphenols: one where polyphenols impact allergen-IgE complex formation 
and another one where the polyphenols impact on the complex binding to their 
receptor (FcεRI) on mast cells [15].
Our results also suggest that oleuropein seems to block signaling pathways 
downstream of cytosolic calcium increase. However, further research is needed in 
order to explain the exact molecular mechanisms of these actions.
Despite the strong biochemical evidence, we considered a morphological evalu-
ation necessary to reinforce the validity of our initial findings. Thus, a second set of 
experiments was designed to analyze the effect of the hydroxytyrosol and oleuro-
pein on mast cell morphology by light and electron microscopy.
Peritoneal mast cells were easily identified by the presence of a cytoplasm 
dominated by distinctive secretory granules which stain metachromatically 
(Figure 5A–J). A representative mast cell from the basal group is shown 
in Figure 5A. Tightly packed secretory granules dominate the cytoplasm. 
Characteristic mast cells stimulated with concanavalin A, compound 48/80, and 
calcium ionophore A23187 are shown in Figure 5B–D, respectively. Cell surface 
disruption, typical of degranulating mast cells, may be observed. Figure 5E–G 
show mast cells treated with 100 μM hydroxytyrosol, for 10 min, prior to the 
challenge with concanavalin A, compound 48/80, and calcium ionophore A23187, 
respectively. Figure 5H–J show mast cells treated with 100 μM oleuropein, 
for 10 min, prior to the challenge with concanavalin A, compound 48/80, and 
calcium ionophore A23187, respectively. The morphology of the cells treated with 
the polyphenols shows a lower degree of degranulation than that of secretagogue 
samples.
Figure 6A–J shows mast cells observed under transmission electron micro-
scope. Figure 6A shows a characteristic view of the basal mast cell population. 
These cells are characterized by a non-segmented, irregular nucleus with only 
moderate nuclear chromatin condensation, narrow surface folds, and numerous 
secretory granules regularly distributed throughout the cell cytoplasm. Almost 
all granules display either round or oval profiles and appear homogenously dense. 
Representative mast cells from the concanavalin A-, compound 48/80-, and 
calcium ionophore A23187-treated group are shown in Figure 6B–D, respectively. 
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These cells display obvious morphological changes and show evidence of increased 
granule release by exocytosis compared to basal cells. Mast cells exhibit a cytoplasm 
with irregular secretory granules showing various degrees of electron densi-
ties. Perigranular dilated and electron-lucent spaces surround some granules. 
Some of these spaces look fused, forming multiple cavities and intracytoplasmic 
channels. Figure 6E–G show mast cells treated with 100 μM hydroxytyrosol, 
for 10 min, prior to the challenge with concanavalin A, compound 48/80, and 
calcium ionophore A23187, respectively. Figure 6H–J show mast cells treated 
with 100 μM oleuropein, for 10 min, prior to the challenge with concanavalin A, 
compound 48/80, and calcium ionophore A23187, respectively. The morphology 
of the polyphenol-treated cells shows a lower degree of degranulation than that of 
secretagogue samples.
Our biochemical results about β-hexosaminidase release are consistent with 
those obtained by light and electron microscopy.
Figure 5. 
Light microscopic photographs of peritoneal mast cells (toluidine blue stain). Mast cells were preincubated 
with 100 μM hydroxytyrosol or oleuropein for 10 min and then stimulated with 200 μg/ml concanavalin A, 
10 μg/ml compound 48/80, or 50 μg/ml calcium ionophore A23187, for 10 min at 37°C. After incubations, cells 
were fixed and stained for light microscopy. (A) Basal. The cytoplasm is dominated by closely packed secretory 
granules. (B–D) Concanavalin A (ConA), compound 48/80 (48/80), and calcium ionophore A23187 (A23187), 
respectively. Degranulating cells may be seen. (E–G) hydroxytyrosol + ConA, hydroxytyrosol + 48/80, and 
hydroxytyrosol + A23187, respectively. (H–J) Oleuropein + ConA, oleuropein + 48/80, and oleuropein + A23187, 
respectively. The morphology of the polyphenol-treated cells shows a lower degree of degranulation than that of 
secretagogue samples. 600×.
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4. Conclusions
In conclusion, our present findings reveal for the first time that hydroxytyrosol 
and oleuropein, the major phenolic compounds in olive, inhibit mast cell degranu-
lation triggered by both immune and nonimmune pathways. Our discoveries also 
suggest that olive polyphenols, especially hydroxytyrosol and oleuropein, may 
provide insights to develop useful tools to prevent and treat mast cell-mediated 
disorders. These findings may be of interest to the immunopharmacology industry 
or could even lead in determining the ideal concentrations of each component in 
Figure 6. 
Transmission electron micrographs showing peritoneal mast cells. Mast cells were preincubated with 100 μM 
hydroxytyrosol or oleuropein for 10 min and then stimulated with 200 μg/ml concanavalin A, 10 μg/ml 
compound 48/80, or 50 μg/ml calcium ionophore A23187, for 10 min at 37°C. After incubations, cells were 
processed for electron microscopy. (A) Basal. A non-segmented nucleus (N), narrow surface folds (red 
arrows), and numerous secretory granules (G) distributed throughout the cell cytoplasm are observed. (B–D) 
Concanavalin A (ConA), compound 48/80 (48/80), and calcium ionophore A23187 (A23187), respectively. 
Granules surrounded by perigranular dilated and electron-lucent spaces are evident. Some granules are seen 
out of mast cell cytoplasm, and others appear fused, forming cavities and intracytoplasmic channels (asterisk). 
(E–G) Hydroxytyrosol + ConA, hydroxytyrosol + 48/80, and hydroxytyrosol + A23187, respectively. (H–J) 
Oleuropein + ConA, oleuropein + 48/80, and oleuropein + A23187, respectively. Polyphenol-treated cells show 
minimal degranulation. 5000×.
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virgin olive oils to be able to label them as healthy oils. However, further tests are 
needed in order to generate hypoallergenic products via polyphenol treatment.
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